Angiogenic Therapy Against Peripheral Arterial Disease with bone marrow derived MSC grown in platelet-rich plasma
Not Applicable
- Conditions
- Peripheral arterial disease
- Registration Number
- JPRN-UMIN000021426
- Lead Sponsor
- ational Center for Global Health and Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
Not provided
Exclusion Criteria
* The patient with remarkable short life expectancy * Patient with the past which is alcohol or drug dependence within 3 months of past * Patient with malignant neoplasms and the patient who has the past within 5 years * The patient who judged that there was a possibility of the malignant tumor * Patient with severe diabetic retinopathy * The patient who can't get informed consent * The patient who judged that he was unsuitable to this trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method